CL2013002521A1 - Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios - Google Patents

Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios

Info

Publication number
CL2013002521A1
CL2013002521A1 CL2013002521A CL2013002521A CL2013002521A1 CL 2013002521 A1 CL2013002521 A1 CL 2013002521A1 CL 2013002521 A CL2013002521 A CL 2013002521A CL 2013002521 A CL2013002521 A CL 2013002521A CL 2013002521 A1 CL2013002521 A1 CL 2013002521A1
Authority
CL
Chile
Prior art keywords
cycloamino
carboxamide
intermediates
preparing
urea derivatives
Prior art date
Application number
CL2013002521A
Other languages
English (en)
Inventor
Bernhard Erb
Isabelle Sylvie Gallaou
Florian Karl Kleinbeck
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013002521(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2013002521A1 publication Critical patent/CL2013002521A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
CL2013002521A 2011-03-03 2013-09-02 Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios CL2013002521A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03

Publications (1)

Publication Number Publication Date
CL2013002521A1 true CL2013002521A1 (es) 2014-02-14

Family

ID=45787206

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013002521A CL2013002521A1 (es) 2011-03-03 2013-09-02 Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios

Country Status (32)

Country Link
US (3) US9650373B2 (es)
EP (1) EP2681192B1 (es)
JP (1) JP6022485B2 (es)
KR (1) KR101851421B1 (es)
CN (2) CN106083840B (es)
AR (2) AR088714A1 (es)
AU (1) AU2012222346B2 (es)
BR (1) BR112013021882A2 (es)
CA (1) CA2828509C (es)
CL (1) CL2013002521A1 (es)
CO (1) CO6751286A2 (es)
DK (1) DK2681192T3 (es)
EA (4) EA032802B1 (es)
EC (1) ECSP13012914A (es)
ES (1) ES2663717T3 (es)
GT (1) GT201300211A (es)
HU (1) HUE036319T2 (es)
IL (1) IL228023A (es)
MA (1) MA34982B1 (es)
MX (2) MX347348B (es)
MY (1) MY163214A (es)
NO (1) NO2681192T3 (es)
PE (1) PE20140917A1 (es)
PL (1) PL2681192T3 (es)
PT (1) PT2681192T (es)
SG (1) SG192793A1 (es)
SI (1) SI2681192T1 (es)
TN (1) TN2013000354A1 (es)
TW (2) TWI597279B (es)
UA (1) UA112539C2 (es)
WO (1) WO2012117071A1 (es)
ZA (1) ZA201306174B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
JP7014737B2 (ja) 2017-01-20 2022-02-01 株式会社ペーターズ スケートボード用ハンドル及びハンドル付きスケートボード
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
BR0013899A (pt) 1999-09-10 2003-07-08 Merck & Co Inc Composto, composição farmacêutica, processos de tratamento ou prevenção de câncer, de uma doença em que a angiogênese esteja implicada, da vascularização retinal, da retinopatia diabética, da degeneração macular relacionada a idade, de doenças inflamatórias, de uma doença ou condições dependentes da tirosina quinase, de patologias associadas com ossos, e, processos para produzir uma composição farmacêutica, e de reduzir ou prevenir dano tecidual em seguida a um evento isquêmico cerebral
TW200519106A (en) * 2003-05-02 2005-06-16 Novartis Ag Organic compounds
US8455658B2 (en) * 2006-01-25 2013-06-04 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
CN101952282A (zh) * 2007-12-20 2011-01-19 诺瓦提斯公司 用作pi 3激酶抑制剂的噻唑衍生物
EP2235983B1 (en) * 2007-12-21 2011-07-20 Telefonaktiebolaget LM Ericsson (publ) Method, apparatus and computer program for handover from a first access point to a second access point
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
MY163214A (en) 2017-08-30
BR112013021882A2 (pt) 2016-07-19
IL228023A0 (en) 2013-09-30
ECSP13012914A (es) 2013-11-29
EA201792068A2 (ru) 2018-01-31
GT201300211A (es) 2014-12-30
ZA201306174B (en) 2014-05-28
DK2681192T3 (en) 2018-04-16
US20170355677A1 (en) 2017-12-14
CN103402982A (zh) 2013-11-20
JP6022485B2 (ja) 2016-11-09
AR088714A1 (es) 2014-07-02
WO2012117071A1 (en) 2012-09-07
UA112539C2 (uk) 2016-09-26
TWI607994B (zh) 2017-12-11
CA2828509C (en) 2018-11-20
EA201691331A1 (ru) 2017-01-30
EP2681192A1 (en) 2014-01-08
CN106083840A (zh) 2016-11-09
TWI597279B (zh) 2017-09-01
KR101851421B1 (ko) 2018-04-23
CN106083840B (zh) 2020-01-03
SI2681192T1 (en) 2018-04-30
AU2012222346A1 (en) 2013-08-29
PL2681192T3 (pl) 2018-06-29
KR20140009432A (ko) 2014-01-22
EA201792068A3 (ru) 2018-05-31
NZ614173A (en) 2015-04-24
TW201722916A (zh) 2017-07-01
US20170240509A1 (en) 2017-08-24
PT2681192T (pt) 2018-04-02
US9776966B2 (en) 2017-10-03
ES2663717T3 (es) 2018-04-16
HUE036319T2 (hu) 2018-06-28
US9650373B2 (en) 2017-05-16
MX2013010132A (es) 2013-10-30
PE20140917A1 (es) 2014-08-14
MX351740B (es) 2017-10-26
CO6751286A2 (es) 2013-09-16
JP2014511387A (ja) 2014-05-15
EA201892052A1 (ru) 2019-02-28
MA34982B1 (fr) 2014-03-01
AR123584A2 (es) 2022-12-21
TW201247660A (en) 2012-12-01
AU2012222346B2 (en) 2015-05-07
SG192793A1 (en) 2013-09-30
TN2013000354A1 (en) 2015-01-20
EA032802B1 (ru) 2019-07-31
CN103402982B (zh) 2016-07-13
MX347348B (es) 2017-04-17
CA2828509A1 (en) 2012-09-07
EA025381B1 (ru) 2016-12-30
IL228023A (en) 2017-04-30
EP2681192B1 (en) 2017-12-27
US10059670B2 (en) 2018-08-28
NO2681192T3 (es) 2018-05-26
US20130331579A1 (en) 2013-12-12
EA201391267A1 (ru) 2014-01-30

Similar Documents

Publication Publication Date Title
HRP20170961T1 (hr) Postupak dobivanja karbamoilpiridonskih derivata i međuprodukata
EP2744336A4 (en) METHOD AND INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF MACROLACTAMEN
CO6890099A2 (es) Nuevos derivados dihidroquinolina-2-ona
CO7061068A2 (es) Derivados de polimixina
BR112014009302A2 (pt) processo para preparar derivativos de quinolina
BR112013023064A2 (pt) processo de síntese de derivados de cetobenzofurano
BR112014007958A2 (pt) método
BR112014001237A2 (pt) método
BR112014001851A2 (pt) método
BR112014009795A2 (pt) método
CL2013002521A1 (es) Proceso de preparación de derivados de 2-carboxamida-cicloamino-urea; y compuestos intermediarios
CO6960557A2 (es) Derivados de 2-yodo-imidazol
HK1194733A1 (zh) 製備 -酰基- -苯基磺酰基脯氨酰胺衍生物的方法及中間體
ZA201306212B (en) An improved process for the preparation of voriconazole and intermediates thereof
DK2809343T3 (da) Fremgangsmåde til fermentering
DK2476534T3 (da) Fremgangsmåde til formning
CO6852074A2 (es) Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida
DK2591119T3 (da) Fermenteringsprocess
BR112014013028A2 (pt) método de produção de soluções
DE112011104700A5 (de) Schleifverfahren
FI20110160A0 (fi) Substituutio menetelmä
TH1401000168B (th) กรรมวิธีสำหรับการผลิตผลิตภัณฑ์ที่ผ่านการหล่อที่ได้รับการปิดคลุม
PL394949A1 (pl) Sposób otrzymywania etanolu metoda fermentacji ciaglej
TH1301003712B (th) วิธีการสำหรับการปรับปรุงคุณภาพพืช
TH115510B (th) วิธีการก่อรูปเป็นชิ้นส่วนมีหน้าแปลน